NIH to Launch Human Safety Study of Ebola Vaccine Candidate

Thursday, August 28, 2014

Trial is First in Series of Accelerated Safety Studies of Ebola Vaccines

Initial human testing of an investigational vaccine to prevent Ebola virus disease will begin next week by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.